[1]
Abdurrahman, A., Rijal, M.A.S., Yusuf, H., Norhayati and Rizaldi, G. 2024. In silico study of naringin as an anti-HER-2 receptor in the treatment of breast cancer. Borneo Journal of Pharmascientech. 8, 2 (Oct. 2024), 137-148. DOI:https://doi.org/10.51817/bjp.v8i2.535.